Correction: Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials
- PMID: 32303617
- PMCID: PMC7204617
- DOI: 10.1136/jitc-2019-000492corr1
Correction: Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials
Erratum for
-
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials.J Immunother Cancer. 2020 Jan;8(1):e000492. doi: 10.1136/jitc-2019-000492. J Immunother Cancer. 2020. PMID: 31996395 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources